8-K
filed May 29, 2026, 5:04 PM ET
ticker TNYA
CIK 0001858848
other material
confidence high
sentiment neutral
materiality 0.50
Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors
Tenaya Therapeutics, Inc.
- Shareholders approved amended 2021 Equity Incentive Plan with one-time increase of 6,509,966 shares (~3% of outstanding).
- Annual evergreen cap removed; future yearly increase remains 4% of outstanding shares per fiscal year.
- Class II directors Amy Burroughs, Karah Parschauer, and Catherine Stehman-Breen elected with >86M votes each.
- Deloitte & Touche ratified as independent auditor for FY2026 with 135.6M votes for.
- Plan amendments also limit shares issuable as incentive stock options to 15M total.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tenaya Therapeutics, Inc. shareholders approved Election of Class II Directors at the 2026-05-27 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-27
Exact text from the filing
Each director nominee was duly elected to serve until the 2029 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tenaya Therapeutics, Inc. shareholders approved Approval of the Company’s Amended and Restated 2021 Equity Incentive Plan at the 2026-05-27 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-05-27
Exact text from the filing
The stockholders approved the amendment and restatement of the Company’s 2021 Equity Incentive Plan.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Tenaya Therapeutics, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-05-27 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-27
Exact text from the filing
The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.